Research Study

A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Sclerosing Cholangitis Without Cirrhosis
Principal Investigator 
Eric M. Yoshida

Overview

Body Locations and Systems 
Liver Diseases
ClinicalTrials.gov# 
NCT02943460
Status 
Recruiting
Study Start/End 
Aug 4, 2017 to May 31, 2027
Locations 
Diamond Health Care Centre
Name/Title 
Jo-Ann Ford/Clinical Research Coordinator
Phone 
604-875-5705
Email Address 
joann.ford@vch.ca
Purpose of Study 

The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in adults with primary sclerosing cholangitis (PSC).

Eligibility 

Please see Clinicaltrials.gov

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.